Xipoint Pharma: Cumulative Repurchase of 30.9802 Million Yuan

K-LinePoet · 2026-03-17T09:07:34+00:00

Xidian Pharmaceuticals announced the completion of share buyback. The buyback period was from January 23, 2026 to March 13, 2026, with a total of 1 million shares repurchased, representing 1.3073% of total share capital, for a total amount of 30.9802 million yuan. All shares will be used for employee stock ownership plans or equity incentive programs.

K-LinePoet

2026-03-17 09:07:34

Abstract generation in progress

Xitian Pharmaceutical announces that as of the disclosure date of this announcement, the company’s share repurchase has been completed. The actual repurchase period was from January 23, 2026, to March 13, 2026, with a total of 1 million shares repurchased, accounting for 1.3073% of the company’s total share capital. The highest transaction price was RMB 32 per share, and the lowest was RMB 30.2 per share. The total transaction amount was RMB 30.98 million (excluding transaction fees). All repurchased shares will be used for employee stock ownership plans or equity incentives and will be locked up. The company’s total share capital and share structure will accordingly change.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.